Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Hendrik Jütte"'
Publikováno v:
Visc Med
Background: Digital pathology, in its primary meaning, describes the utilization of computer screens to view scanned histology slides. Digitized tissue sections can be easily shared for a second opinion. In addition, it allows tissue image analysis u
Autor:
Moritz Reike, Hendrik Jütte, Marko Brock, Andrea Tannapfel, Julian Hanske, Karl H. Tully, Christian von Bodman, Rein-Jüri Palisaar, Florian Roghmann, Joachim Noldus, Max Schulmeyer, Rudolf Moritz
Publikováno v:
BJU internationalReferences. 128(5)
Objective To identify patients at risk for biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy (RP) with intra-operative whole-mount frozen section (FS) of the prostate. Material and methods We examined differences in BC
Autor:
Christian Bolenz, Hendrik Jütte, Felix Wezel, Arndt Hartmann, Sebastian Eidt, Joachim Noldus, Ralph M. Wirtz, Moritz Reike, Maximilian C. Kriegmair, Philipp Erben, Andrea Tannapfel, Karl H. Tully, Markus Eckstein, Florian Roghmann, Veronika Weyerer
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 473, p 473 (2021)
Journal of Personalized Medicine
Volume 11
Issue 6
Journal of Personalized Medicine
Volume 11
Issue 6
Patients with muscle-invasive bladder cancer (MIBC) that underwent neoadjuvant chemotherapy (NAC) prior to radical cystectomy (RC) show improved overall survival, especially those with pathological complete response (pCR). The response to NAC accordi
Autor:
Anke Reinacher-Schick, Dirk Arnold, Klaus Gerwert, C. Sternemann, Frederik Großerüschkamp, A-L. Kraeft, Axel Mosig, Celine Lugnier, N. Timmesfeld, D. Schuhmacher, O. Overheu, L. Mueller, Hendrik Jütte, Inke Sabine Feder, Waldemar Uhl, Christian Teschendorf, S.M. Schörner, Andrea Tannapfel, S. Wisser
Publikováno v:
Annals of Oncology. 32:S531-S532
Autor:
Maximilian Burger, Christian Bolenz, Helge Taubert, Jonas Jarczyk, Bernd Wullich, Arndt Hartmann, Maximilian C. Kriegmair, Florian Roghmann, Hendrik Jütte, Stefan Porubsky, Ademi Santiago-Walker, Danijel Sikic, Karl H. Tully, Markus Eckstein, Friedemann Zengerling, Robert Stoehr, Philipp Erben, Veronika Weyerer, Ralph M. Wirtz, Johannes Breyer, Jost von Hardenberg
Publikováno v:
Urology. 157
Objective To examine the disease-specific survival(DSS) after checkpoint inhibitor(CPI) therapy based on FGFR alterations and FGFR mRNA expression levels in patients with metastatic urothelial cancer(mUCa) within a multi-center cohort. Methods Within
Autor:
Hansjörg Meyer, Dieter Schilling, Hendrik Jütte, Jürgen F. Riemann, Oliver G. Opitz, Helmut Hildebrandt, Andreas Teufel, Axel Naumann, Alexander Hann, Dietrich Hüppe, Thomas Ganslandt, Alexander Meining
Publikováno v:
Zeitschrift für Gastroenterologie. 59:473-474
Autor:
Hendrik Jütte, Michael A. Nauck, Juris J. Meier, Eduard Montanya, Sandra Ueberberg, Waldemar Uhl, Wolfgang E. Schmidt, Andrea Tannapfel
Publikováno v:
Diabetes, Obesity and Metabolism. 18:1253-1262
Aims/hypothesis Incretin-based therapies have been associated with an increased risk of pancreatitis. Recently, various histological abnormalities have been reported in human pancreatic tissue from brain-dead organ donors that had been exposed to inc
Autor:
Andrea Tannapfel, Hendrik Jütte
Publikováno v:
Der Pathologe. 37:299-303
Tumors of the liver, intrahepatic and extrahepatic bile ducts as well as the gallbladder are very heterogeneous and show different biological behavior. The 4‑stage (i.e. well, moderately, poorly and undifferentiated) grading system for hepatocellul
Autor:
Karl H. Tully, Markus Eckstein, Sven Wach, Thomas Stefan Worst, Friedemann Zengerling, Maximilian C Kiregmair, Helge Taubert, Danijel Sikic, Maximilian Burger, Stefan Porubsky, Philipp Erben, Christian Bolenz, Ademi E. Santiago-Walker, Florian Roghmann, Jonas Jarczyk, Johannes Breyer, Arndt Hartmann, Veronika Weyerer, Robert Stoehr, Ralph M. Wirtz, Hendrik Jütte
Publikováno v:
The Journal of Urology. 203:e939
Autor:
Frederik Großerueschkamp, Heiko U. Käfferlein, Hendrik Jütte, Thomas Brüning, Klaus Gerwert, Karin Schork, Joachim Noldus, Martin Eisenacher, Kathrin E. Witzke, Angela Kallenbach-Thieltges, Katrin Marcus, Thilo Bracht, Melanie Horn, Andrea Tannapfel, Nicolas von Landenberg, Florian Roghmann, Barbara Sitek
Publikováno v:
The American journal of pathology. 189(3)
Histopathological differentiation between severe urocystitis with reactive urothelial atypia and carcinoma in situ (CIS) can be difficult, particularly after a treatment that deliberately induces an inflammatory reaction, such as intravesical instill